Q92.0
Whole chromosome trisomy, nonmosaicism (meiotic nondisjunction)
Clinical Classification Guidelines
Medical Intelligence & Overview
Whole chromosome trisomy, classified under ICD-10 code Q92.0, is a genetic condition where an individual has an extra copy of a particular chromosome. This genetic abnormality occurs during the formation of reproductive cells and results in the presence of three copies of a chromosome instead of the usual two. The most common example is Down syndrome, which involves an extra chromosome 21. Since this condition involves a nonmosaic pattern due to meiotic nondisjunction, every cell in the body carries this extra chromosome, impacting physical features, development, and health.
Causes & Symptoms
Clinical Causes: Nondisjunction during meiosis: An error in the cell division process where chromosomes fail to separate properly, leading to an egg or sperm cell with an extra chromosome. Advanced maternal age: Increased age in mothers is associated with a higher risk of nondisjunction events. Genetic susceptibility: Certain genetic factors may predispose chromosomes to nondisjunction, although specific causes are not fully understood. Environmental factors: Some exposures to radiation or harmful chemicals are suspected to influence nondisjunction, but evidence remains inconclusive.
Key Symptoms: Distinct physical features depending on the specific chromosome involved, such as characteristic facial features in trisomy 21 (Down syndrome). Intellectual disability or developmental delays. Poor muscle tone (hypotonia) in infants, leading to difficulties with feeding and motor skills. Congenital heart defects or other structural abnormalities. Delayed growth and short stature. Health problems affecting the gastrointestinal, immune, or endocrine systems. Increased risk of certain medical conditions like leukemia or Alzheimer's disease, especially in trisomy 21.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically begins with prenatal screening tests, such as ultrasound and blood tests, which assess risk factors. Confirmatory diagnosis is made through invasive procedures like amniocentesis or chorionic villus sampling (CVS), where fetal chromosomes are analyzed via karyotyping. Postnatal diagnosis involves physical examination and chromosomal analysis to identify the trisomy pattern in cells collected from the individual.
Treatment Protocols: There is no cure for whole chromosome trisomy; management focuses on addressing specific health issues and supporting development. Interventions might include:
Clinical Advice & FAQs
Billing Guidance
Is Q92.0 a billable ICD-10 code?
Yes, Q92.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q92.0?
Clinical documentation must specify the nature of Whole chromosome trisomy, nonmosaicism (meiotic nondisjunction) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference